Comparative Analysis of Biological and Functional Properties of Bone Marrow Mesenchymal Stromal Cells Expanded in Media with Different Platelet Lysate Content

被引:4
|
作者
Skific, Marijana [1 ,2 ]
Golemovic, Mirna [1 ,2 ]
Crkvenac-Gornik, Kristina [3 ]
Vrhovac, Radovan [4 ,5 ]
Cepulic, Branka Golubic [1 ,2 ,4 ,6 ]
机构
[1] Univ Hosp Ctr Zagreb, Clin Dept Transfus Med & Transplantat Biol, Kispaticeva 12, HR-10000 Zagreb, Croatia
[2] Univ Appl Hlth Sci, Zagreb, Croatia
[3] Univ Hosp Ctr Zagreb, Div Cytogenet, Dept Lab Diagnost, Zagreb, Croatia
[4] Univ Zagreb, Sch Med, Zagreb, Croatia
[5] Univ Hosp Ctr Zagreb, Dept Hematol, Zagreb, Croatia
[6] Univ Split, Univ Dept Hlth Studies, Split, Croatia
关键词
Mesenchymal stromal cells; Platelet lysate; Fetal bovine serum; In vitro expansion; Chromosome aberrations; FETAL BOVINE SERUM; UMBILICAL-CORD BLOOD; STEM-CELLS; PROGENITOR CELLS; ADIPOSE-TISSUE; EXPANSION; THERAPY; TRANSFORMATION; CULTURES; COMPLICATIONS;
D O I
10.1159/000492581
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Due to their ability to induce immunological tolerance in the recipient, mesenchymal stromal cells (MSCs) have been utilized in the treatment of various hematological and immune- and inflammation-mediated diseases. The clinical application of MSCs implies prior in vitro expansion that usually includes the use of fetal bovine serum (FBS). The present study evaluated the effect of different platelet lysate (PL) media content on the biological properties of MSCs. MSCs were isolated from the bone marrow of 13 healthy individuals and subsequently expanded in three different culture conditions (10% PL, 5% PL, 10% FBS) during 4 passages. The cells cultured in different conditions had comparable immunophenotype, clonogenic potential, and differentiation capacity. However, MSC growth was significantly enhanced in the presence of PL. Cultures supplemented with 10% PL had a higher number of cumulative population doublings in all passages when compared to the 5% PL condition (p < 0.03). Such a difference was also observed when 10% PL and 10% FBS conditions were compared (p < 0.005). A statistically significant difference in population doubling time was determined only between the 10% PL and 10% FBS conditions (p < 0.005). Furthermore, MSCs cultured in 10% PL were able to cause a 66.9% reduction of mitogen-induced lymphocyte proliferation. Three chromosome aberrations were detected in PL conditions. Since two changes occurred in the same donor, it is possible they were donor dependent rather than caused by the culture condition. These findings demonstrate that a 10% PL condition enables a higher yield of MSCs within a shorter time without altering MSC properties, and should be favored over the 5% PL condition. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:226 / 239
页数:14
相关论文
共 50 条
  • [31] MESENCHYMAL STROMAL CELLS EXPANDED WITH PLATELET LYSATE IN THE TREATMENT OF GRAFT VERSUS HOST DISEASE IN SEVERE PEDIATRIC POPULATION
    Lucchini, G.
    Introna, M.
    Dander, E.
    Rovelli, A.
    Balduzzi, A.
    Bonanomi, S.
    Salvade, A.
    Capelli, C.
    Belotti, D.
    Gaipa, G.
    Perseghin, P.
    Lanino, E.
    Chiusolo, P.
    Orofino, M. G.
    Marktel, S.
    Golay, J.
    Rambaldi, A.
    Biondi, A.
    D'Amico, G.
    Biagi, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : S26 - S26
  • [32] Impact of different formulations of platelet lysate on proliferative and immune profile of equine mesenchymal stromal cells
    Yaneselli, Kevin
    Avila, Gimena
    Rossi, Andrea
    Rial, Analia
    Castro, Sabrina
    Estrade, Maria Jose
    Suarez, Gonzalo
    Algorta, Agustina
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [33] Production of human platelet lysate by use of ultrasound for ex vivo expansion of human bone marrow-derived mesenchymal stromal cells
    Bernardi, Martina
    Albiero, Elena
    Alghisi, Alberta
    Chieregato, Katia
    Lievore, Chiara
    Madeo, Domenico
    Rodeghiero, Francesco
    Astori, Giuseppe
    CYTOTHERAPY, 2013, 15 (08) : 920 - 929
  • [34] Immunomodulatory properties of umbilical cord blood-derived mesenchymal stromal cells expanded in the presence of platelet lysate: potential for clinical application
    Bernardo, M.
    Avanzini, M.
    Perotti, C.
    Cometa, A.
    Zaffaroni, N.
    Novara, F.
    Moretta, A.
    Maccario, R.
    Fibbe, W.
    Locatelli, F.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S160 - S160
  • [35] Phenotypic instability of mesenchymal stromal cells isolated and expanded in different growth media
    Fitzgerald, J. C.
    Hanley, S.
    Barry, F.
    CYTOTHERAPY, 2020, 22 (05) : S84 - S84
  • [36] PHENOTYPIC INSTABILITY OF MESENCHYMAL STROMAL CELLS ISOLATED AND EXPANDED IN DIFFERENT GROWTH MEDIA
    Fitzgerald, J. C.
    Hanley, S.
    McInerney, V.
    Krawczyk, J.
    Murphy, M.
    Barry, F.
    CYTOTHERAPY, 2021, 23 (05) : S63 - S63
  • [37] FAST PRODUCTION OF HUMAN PLATELET LYSATE BY PLATELET RICH PLASMA SONICATION FOR THE EX-VIVO EXPANSION OF BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS
    Bernardi, M.
    Albiero, E.
    Alghisi, A.
    Chieregato, K.
    Lievore, C.
    Madeo, D.
    Rodeghiero, F.
    Astori, G.
    CYTOTHERAPY, 2014, 16 (04) : S104 - S104
  • [38] Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts
    Capelli, C.
    Domenghini, M.
    Borleri, G.
    Bellavita, P.
    Poma, R.
    Carobbio, A.
    Mico, C.
    Rambaldi, A.
    Golay, J.
    Introna, M.
    BONE MARROW TRANSPLANTATION, 2007, 40 (08) : 785 - 791
  • [39] Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts
    C Capelli
    M Domenghini
    G Borleri
    P Bellavita
    R Poma
    A Carobbio
    C Micò
    A Rambaldi
    J Golay
    M Introna
    Bone Marrow Transplantation, 2007, 40 : 785 - 791
  • [40] Bone marrow mesenchymal cells: biological properties and clinical applications
    Dominici, M
    Hofmann, TJ
    Horwitz, EM
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2001, 15 (01): : 28 - 37